ID   H7D7BD5
AC   CVCL_1T10
SY   H7D7-BD5; BD5; HepG2-BD5
DR   cancercelllines; CVCL_1T10
DR   Wikidata; Q54872222
RX   PubMed=12619888;
CC   Problematic cell line: Contaminated. Parent cell line (H7D7B) has been shown to be a Hep-G2 derivative (PubMed=12619888).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00560.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1T07 ! H7D7B
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 17
RX   PubMed=12619888; DOI=10.1023/A:1021653506123;
RA   van Pelt J.F., Decorte R., Yap P.S.H., Fevery J.;
RT   "Identification of HepG2 variant cell lines by short tandem repeat
RT   (STR) analysis.";
RL   Mol. Cell. Biochem. 243:49-54(2003).